Navigation Links
HCT in Medical News

Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure

- Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies - Up to 80% of patients may need multiple medications to help them reach blood pressure goals - Single-pill combinations offer effective, ...

DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter

...iation, particularly for TSAT and ferritin. Hb and hct were affected by the day of the week blood was dra...e obtained the first dialysis day of the week. Hb, hct and Ret-H e /CHr values were measured using a Sysm...chieve clinically meaningful accuracy and that HB, hct and reticulocyte Hb (Ret-H e or CHr) were useful ...

Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill

... - Exforge hct combines a proven calcium channel blocker, angiote...) in one pill - In a clinical trial, Exforge hct demonstrated significantly greater reductions in s...essure and many need three or more - Exforge hct can help appropriate patients reach BP goals; offe...

Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008

...ons with peak widths less than 5 sec. The control by Bruker's Hystar™ software supports all proteomics applications on the maxis, micrOTOF-Q II, hct ion trap, Flex MALDI and apex FTMS instrument series for complete, turn-key LC/MS/MS solutions. The new Bruker mass spectrometry products and applicat...

Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment

...end of March 2014, whereby Forest will receive a gradual reduction on profit percentage from its partner Daiichi Sankyo related to Benicar and Benicar hct sales. However, during this period the Benicar profit received will no longer be impacted by salesforce expense as the Company will reallocate those d...

JCI table of contents: Feb. 21, 2008

...c stem cell transplantation (HCT). However, little is known about effective hct approaches to treating individuals with solid tumors. In a new study, Richa...olleagues, at the National Institutes of Health, Bethesda, have outlined an hct approach for the treatment of metastatic kidney cancer that caused tumor re...

DaVita 4th Quarter 2007 Results

...t/V > 1.2 94.4% 93.6% 92.9% Patients with albumin >/= 3.5 83.7% 82.9% 84.0% Patients with hct >/= 33 82.4% 82.8% 84.7% (1) These are non-GAAP financial measures. For a reconciliation of these non-G...
HCT in Medical Technology

Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril

Comparison of BENICAR HCT 40/12.5 and 40/25 mg/day and Amlodipine + Benazepril 5/20 and 10/20 mg/day Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting PARSIPPANY, N.J., May 21, 2007 /PRNewswire/ -- New data presented today at the American Society of Hypertension...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

...gs to achieve their blood pressure goals. Tekturna hct is a single-pill combination of Tekturna((R)) (ali...edications. The FDA approval of Tekturna hct as initial therapy was based on clinical trial dat...pleased the FDA recognizes the benefit of Tekturna hct for the first-line treatment of patients with mode...

Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial

...eotech is developing based upon its first-in-class hct platform. A total of 60 patients were enrolled in ... DuraTech is the leading product in Osteotech's hct platform, which is based on Osteotech's breakthrou...ntroduce additional tissue products based upon its hct platform over the next several years that address ...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

...iSILVER study found that BENICAR (R) and BENICAR hct (R) provided a mean reduction in 24-hour ambulato...sure (BP)-lowering efficacy of BENICAR and BENICAR hct in patients age 65 and older with mild to moderate...e, heart attack and stroke.(2) BENICAR and BENICAR hct are indicated for the treatment of hypertension. T...

New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering

...nation with other antihypertensive agents. BENICAR hct is not indicated for initial therapy. BENICAR and BENICAR hct have not been FDA approved for other indications s...salt retention and increased blood volume. BENICAR hct combines BENICAR with the diuretic hydrochlorothia...

New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)

...lood pressure (BP) of BENICAR hct (placebo: 43.1%). - Six out of 10 (cumulative 60....e to achieve a BP of BENICAR hct (placebo: 6.9%). PARSIPPANY, N.J., May 14 /PRNew...ed the ability of a regimen of BENICAR and BENICAR hct to lower blood pressure beyond 140/90 mm Hg to the...

NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update

...Ox is targeting the therapeutic areas of inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly hct 3012); in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has str...

NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020

...Ox is targeting the therapeutic areas of inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly hct 3012); in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...

NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology

...Ox is targeting the therapeutic areas of inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly hct 3012), in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...

NicOx' Naproxcinod ABPM Data Presented at American Heart Association

...Ox is targeting the therapeutic areas of inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly hct 3012); in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...
HCT in Medical Products

STAT-CRIT HCT Instrument

Description: STAT-CRIT is a rapid, one-step system for measuring hematocrit....
Company:Inverness Point of Care

STAT-CRIT Hct Analyzer

Description: STAT-CRIT is a rapid, one-step system for measuring hematocrit....
Company:Wampole Laboratories

SafeCrit® Microhematocrit Tubes

Description:... easy to read SafeCrit plastic tubes, plain or heparinized. These tubes feature rapid capillary action and have a two-year shelf life. For use in RH12 hct rotor....
Company:Iris Sample Processing (formerly StatSpin, Inc.)

CritSpin Microhematocrit Centrifuge

Description:...ge of important benefits: - 2 minute spin, complete cell packing - Meets NCCLS standards - Read tubes in the rotor, less handling, less risk - Digital hct display reduces chance of error - Accepts glass or SafeCrit plastic tubes - Tube balancing not required, vibration free operation. Approval: C...
Company:Iris Sample Processing (formerly StatSpin, Inc.)
HCT in Biological Technology

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

...o received allogeneic hematopoietic cell transplants (HCT). Non-infectious inflammation of the lung is a common and potentially fatal complication of hct that decreases the exchange of oxygen and carbon dioxide between the lung and blood and, in its severe form, may present as interstitial pneumonitis. ...

Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement

...ring which Forest will have a residual participation in Benicar and Benicar hct profits, but will not be actively promoting those products. The result of t...mportant additional resources to build our franchise of Benicar and Benicar hct into significant products in the antihypertensive market while we built our...

Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement

...r blocker combination product, all indicated for the treatment of hypertension. * Azor is a trademark of Daiichi Sankyo, Inc.; Benicar and Benicar hct are registered trademarks of Daiichi Sankyo, Inc.; and Campral is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Dar...

Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation

... in the United States under license from Merz Pharma GmbH & Co. KGaA of Germany. *Azor is a trademark of Daiichi Sankyo, Inc.; Benicar and Benicar hct are registered trademarks of Daiichi Sankyo, Inc.; and Campral is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Darmst...

Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure

... - Tekturna hct combines first approved direct renin inhibitor wit...monly-used high blood pressure medicines. Tekturna hct is approved for patients not controlled by either ...Pennsylvania Hospital in Pittsburgh, PA. "Tekturna hct offers patients an effective new treatment option ...

One of Nation's Oldest Blood Services Providers Turns to Sysmex America

...ct fit for the blood processing center. The XE-2100D has an easy-to-use operating system and an extended platelet linearity of up to 5,000 x 10/ul and hct linearity up to 75%. Sysmex's state-of-the-art Interlaboratory Quality Control Program features a multi-level, all inclusive quality control material....

NicOx Opens U.S. Headquarters in New Jersey

...Ox is targeting the therapeutic areas of inflammation and cardio-metabolic disease. Resources are focused on two lead compounds, naproxcinod (formerly hct 3012); in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...

Schwartz leaves Merge board; will launch healthcare technology investment fund

...iding business development assistance to the company beyond his previously disclosed departure date of Sept. 1. "While the decision to launch a new hct fund requires me to resign from the board of directors, I plan to continue assisting the company in various new business development activities. It ha...

Analysis of Microarray Data

...man Cancer Institute cDNA microarray. mRNA or aRNA (2 g) was reverse transcribed in the presence of random ninemers and Cy dyes. hct 116 samples were labeled with Cy5-dCTP while RKO cells were labeled with Cy3-dCTP. Analysis of the microarray data was carried o...
Other Tags
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 Developing ... due to the use of cellular models that recapitulate ... the entirety of the disease. , A company ... human cells to precise specifications has created iPSC-derived ... develop environmentally and genetically driven in vitro models of ...
(Date:3/29/2015)... (PRWEB) March 30, 2015 At the ... Helo Commercial introduced the new Fonda wall ... Daily. , Club owners and facilities managers with ... the new, sleek design of the Fonda heater. ... the heater is an immediate upgrade for a sauna, ...
(Date:3/29/2015)... March 30, 2015 Elfster.com, the top-rated ... of its promotional plans to publicize its gift exchange ... holiday season. Known as the leader in Secret Santa ... so that adjacent markets can see the opportunities as ... brand awareness," explained Peter Imburg, CEO of Elster.com. "With ...
(Date:3/29/2015)... 29, 2015 Adults who are comparing ... nationally on the web can now use the QuotesPros.com ... quotes can now be explored while researching the automated ... Learning the differences between what a term policy provides ... challenge for some men and women. Insurers typically provide ...
(Date:3/29/2015)... The Claudia Cohen Research Foundation and ... that Dr. Beth Y. Karlan has been selected as ... Prize for Outstanding Gynecologic Researcher. The $50,000 prize is ... Annual Meeting on Women's Cancer in Chicago. , Dr. ... at the Samuel Oschin Comprehensive Cancer Institute and Director ...
Breaking Medicine News(10 mins):Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 2Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 3Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 4Health News:Helo Commercial Introduces Fonda Sauna Heater and Sauna and Steam Continuing Education Program at IHRSA 2Health News:Gift Exchange Generator Promotion Achieves Early Success, Announces Elfster 2Health News:Permanent Life Insurance Quotes Now Offered Through Web Search System at Insurer Website Online 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4
(Date:3/23/2015)... ANGELES , March 23, 2015  In the ... Federal fraud case conviction losses. This figure accounts for ... which, according to The Nilson Report, exceeds $11 billion ... investigative tool after a crime has occurred. Investor ... and polygraph expert Joe Paolella partnered to ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report ... markets for Iris Biometrics in US$ Thousands. The report provides ... , Japan , Europe ... , and Latin America . ...
(Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
Other Contents